Neurvana Medical, LLC — Form D/A
Neurvana Medical, LLC of TUSTIN, CA, a company, filed a Form D amendment with the SEC on 2017-10-23. The offering totals $5.5M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-10-23
- Form: D/A
- Accession: 0001719372-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $3.2M
- Remaining: $2.3M
- Investors: 19
- Date of first sale: 2016-10-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-297234
Issuer
- Name: Neurvana Medical, LLC
- CIK: 0001719372
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 3002 DOW AVENUE, SUITE 138, TUSTIN, CA, 92780
- Phone: 949-743-1158
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Ferrera | Director | Lake Forest, CA |
| Jeffrey G Goldberg | Director | Tustin, CA |
| Kenneth G Baker | Director | Tustin, CA |
| Robert G Abrams | Director | Tustin, CA |
| Thomas G Fogarty | Director | Tustin, CA |
| Thomas G Fogarty | Executive Officer | Tustin, CA |
Other filings by this issuer (1)
More